Journal of Pharmaceutical Policy and Practice
[Accessed 7 Sep2019]
| 4 September 2019
Assessing national governance of medicine promotion: an exploratory study in Ghana to trial a structured set of indicators
Authors: Marcia McLean, Jillian Clare Kohler and Danny Edwards
Two billion people worldwide, predominantly in low- and middle-income countries, cannot consistently access required essential medications, thus affecting their ability to attain optimal health outcomes. Access to appropriate medicines may be compromised due to issues involving cost, availability, quality, and prescribing practices, and system-wide factors such as a lack of transparency and accountability. Pharmaceutical promotional practices impact many of these issues, thus influencing the use of appropriate medicines,. Good governance is ultimately the responsibility of national governments through strong health systems with transparent and accountable practices that facilitate appropriate medicine use. We designed a structured set of indicators, based on existing tools, to assess the strength of the national governance of pharmaceutical promotion. In this exploratory study, we trialed the indicators in Ghana.